3.0
Apr 22, 2026
Current employee, more than 5 years
Cambridge, MA
Recommend
CEO approval
Business Outlook
Pros
The science and innovation are amazing with a strong pipeline for future launches.
Cons
Aspiring to be a multi product and multi therepeutic Pharma company that doesn’t want to let go of its biotech roots. Work is poorly orchestrated with teams and orgs often working in silos. High turnover and frequent change makes it challenging to ensure continuity of work. Huge push to create agents/AI tools with limited resources and low understanding of how to execute effectively.